Empower the Immune System to Treat Glioblastoma: DNA as Medicine

Time: 3:05 pm
day: Day One


  • Explore DNA medicines that have the potential to create robust,
    antigen-specific T cell responses
  • Evaluate Inovio’s DNA medicine, INO-5401 has promising, early data in
    GBM showing early efficacy, and immunogenicity
  • Discuss Inovio’s DNA medicine, its technology, and other promising
    approaches to GBM therapy will be discussed